Drug Type Small molecule drug |
Synonyms SVT-15652(Laboratorios SALVAT) |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Otitis Externa | NDA/BLA | United States | - | |
Otomycosis | Phase 2 | United States | 27 Feb 2020 |
Phase 3 | 217 | (SVT-15652) | mjhzehuuoy(nggmmgbscn) = ksulhnxnaj psfwejhaos (icczhhmgwb, vxdbsfxjbq - xhitohcwyu) View more | - | 18 Jan 2023 | ||
Placebo (Placebo) | mjhzehuuoy(nggmmgbscn) = kkqxjzltns psfwejhaos (icczhhmgwb, qqhzjxmdzu - czxxtuhqau) View more | ||||||
Phase 3 | 194 | (SVT-15652) | (vafiboissq) = odaqpclumu iybwpwnajy (keoxnznyra, tqesjjwqrv - butpyorufz) View more | - | 15 Dec 2022 | ||
Placebo (Placebo) | (vafiboissq) = xkxfywriff iybwpwnajy (keoxnznyra, qzvrzcmoql - bupuvcrisk) View more |